公司名稱: 卓珈控股集團有限公司 (「本公司」)(於開曼群島註冊成立之有限公司) 呈交日期: 2026年2月2日 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 I. 法定/註冊股本變動 截至月份: 2026年1月31日 狀態: 新提交 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01827 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 2,000,000,000 | | HKD | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | 20,000,000 | 本月底法定/註冊股本總額： H ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 卓珈控股集團有限公司 (「本公司」)(於開曼群島註冊成立之有限公司) 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01827 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | | 20,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | ...

格隆汇12月30日丨卓珈控股(01827.HK)宣布，邓崇坚已获委任为公司执行董事，自2025年12月30日起生 效。 ...

卓珈控股(01827)发布公告，邓崇坚先生已获委任为本公司执行董事，自2025年12月30日起生效。 ...

Miricor Enterprises Holdings Limited 獨立非執行董事 鄭輔國先生 鄭毓和先生 李偉君先生 卓珈控股集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1827） 董事名單與其角色和職能 卓珈控股集團有限公司董事會（「董事會」）成員載列如下： 執行董事 黎珈而女士 （主席兼行政總裁） 何子亮先生 林秉恩醫生 鄧崇堅先生 | | 董事委員會 | | | | --- | --- | --- | --- | | 董事 | 審核委員會 | 薪酬委員會 | 提名委員會 | | 黎珈而女士 | | 成員 | 主席 | | 何子亮先生 | | | | | 林秉恩醫生 | | | | | 鄧崇堅先生 | | | | | 鄭輔國先生 | 成員 | | 成員 | | 鄭毓和先生 | 主席 | 主席 | 成員 | | 李偉君先生 | 成員 | 成員 | | 董事會設立3個董事委員會。下表提供各董事會成員在這些委員會中所擔任的職位。 香港，2025年12月30日 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 鄧先生為特許金融分析師協會的特許金融分析師及香港會計師公會的資深會員。於 2001年，鄧先生自香港理工大學取得會計學（榮譽）工商管理學士學位。 1 鄧先生已就其獲委任為本公司執行董事與本公司訂立服務協議，任期自2025年12月 30日開始，在任何一方向另一方發出不少於三個月的書面通知予以終止的規限下， 任期將持續至彼獲委任為本公司執行董事當日起計第三屆股東週年大會（或倘該大 會押後舉行，則續會）當日（包括該日）。鄧先生現時擔任本公司首席財務官，有權收 取每月薪金169,750港元。鄧先生擔任執行董事將不會收取任何董事袍金，惟有權享 有由董事會及薪酬委員會根據本集團的經營業績及鄧先生的表現全權釐定的酌情 花紅。 於本公告日期，鄧先生並無於本公司股份中持有證券及期貨條例（香港法例第571章） 第XV部項下所界定的任 ...

Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：1827） NOTIFICATION LETTER 通知信函 Dear Non-Registered Shareholders, Miricor Enterprises Holdings Limited (the "Company") – Notice of publication of Interim Report 2025/2026 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.miricor.com and the website of ...

Dear Registered Shareholders, Miricor Enterprises Holdings Limited (the "Company") Miricor Enterprises Holdings Limited 卓珈控股集團有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：1827） NOTIFICATION LETTER 通知信函 8 December 2025 – Notice of publication of Interim Report 2025/2026 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications are now available on the Company's website at www.miricor.com and ...

Financial Performance - The Group's revenue for the six months ended September 30, 2025, was approximately HK$160.1 million, a decrease of approximately HK$40.0 million or 20.0% compared to HK$200.1 million for the same period in 2024[9] - Loss attributable to the owners of the Company was approximately HK$0.3 million for the six months ended September 30, 2025, compared to a loss of HK$0.6 million for the same period in 2024[9] - The Company reported a profit before tax of HK$0.96 million for the six months ended September 30, 2025, compared to a profit of HK$1.76 million for the same period in 2024[10] - The total comprehensive loss for the period ended September 30, 2025, was HK$189,000, compared to a total comprehensive loss of HK$156,000 for the same period in 2024, indicating a worsening of approximately 21.1%[13] - The Group reported a loss attributable to ordinary equity holders of HK$335,000 for the six months ended September 30, 2025, an improvement from a loss of HK$630,000 in the same period of 2024[42] Assets and Liabilities - Total non-current assets decreased from HK$156.3 million as of March 31, 2025, to HK$132.1 million as of September 30, 2025[11] - Current assets increased from HK$314.99 million as of March 31, 2025, to HK$322.59 million as of September 30, 2025[11] - The net current assets increased from HK$51.14 million as of March 31, 2025, to HK$59.92 million as of September 30, 2025[11] - As of September 30, 2025, total non-current liabilities decreased to HK$44,619,000 from HK$59,866,000 as of March 31, 2025, representing a reduction of approximately 25.5%[12] - The net assets as of September 30, 2025, were HK$147,373,000, slightly down from HK$147,562,000 as of March 31, 2025, indicating a decrease of about 0.13%[12] Revenue Breakdown - Revenue from treatment services was HK$141,592,000, down 17% from HK$170,722,000 in the previous year[33] - Revenue from skincare products decreased by 37% to HK$18,477,000 from HK$29,336,000[33] - Total revenue for the six months ended September 30, 2025, was HK$160,080,000, a decrease of 20% compared to HK$200,076,000 for the same period in 2024[33] Cash Flow and Liquidity - For the six months ended September 30, 2025, the net cash flows from operating activities were HK$31,763,000, a decrease of 13.4% compared to HK$36,601,000 for the same period in 2024[14] - Cash and cash equivalents at the end of the period were HK$81,923,000, down from HK$89,092,000 at the end of the same period in 2024, reflecting a decrease of about 8.1%[14] - Cash and cash equivalents as of September 30, 2025, were approximately HK$186.6 million, indicating a stable financial position[94] Operational Efficiency - Staff costs decreased by approximately HK$12.1 million or 16.3%, from approximately HK$74.2 million in the previous period to approximately HK$62.1 million[79] - Property rentals and related expenses decreased by approximately HK$4.1 million or 14.2%, from approximately HK$28.9 million in the previous period to approximately HK$24.8 million[80] - Other expenses, net decreased by approximately HK$12.4 million or 24.1%, from approximately HK$51.4 million in the previous period to approximately HK$39.0 million[82] Corporate Governance - The Company has complied with all applicable code provisions of the Corporate Governance Code during the six months ended 30 September 2025, except for the separation of the roles of chairman and chief executive officer[148] - The independent non-executive Directors have reviewed the implementation of the deed of non-competition and confirmed compliance by the Controlling Shareholders[140] - The Company has established an audit committee consisting of three independent non-executive Directors to oversee financial reporting[156] Market and Strategic Outlook - The Group aims to maintain profitability and core competitiveness through stable and prudent operating strategies amidst a relatively uncertain global economy[73] - The skincare brand XOVĒ is developing its e-commerce channels and sales platform in Mainland China while maintaining physical shops in four high-end shopping malls in Hong Kong[72] - The wellness beauty brand VITAE operates two treatment centres in Hong Kong's core business districts, focusing on creating a balanced aesthetic experience[71] Shareholder Information - As of September 30, 2025, Ms. LAI Ka Yee Gigi holds a long position of 275,000,000 shares, representing 68.75% of the Company's issued share capital[120] - Sunny Bright holds 275,000,000 shares of the Company, representing 68.75% of the issued share capital[127] - Meitu, Inc. is a beneficial owner of 20,000,000 shares, accounting for 5% of the issued share capital[127]

呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01827 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | | 20,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交 ...